UK weighs tighter access to flea and tick products

The UK government is weighing tighter controls on some flea and tick treatments after evidence linked two common active ingredients, fipronil and imidacloprid, to contamination in waterways. The Veterinary Medicines Directorate launched a UK-wide call for evidence on April 16, 2026, asking for data on environmental impacts and on whether changes to supply routes, including more professional oversight at the point of sale, could improve responsible use and disposal. The review does not propose a full ban, but it does explicitly ask whether access to these products should change, a move that could affect over-the-counter availability. The call closes June 11, 2026, and the government says the overall review is expected to take about 12 months. (gov.uk)

Why it matters: For veterinary professionals, this is shaping up as both a prescribing and client-communication issue. UK regulators are balancing animal welfare and parasite control against growing evidence that spot-on ectoparasiticides can enter waterways through wastewater and through treated dogs swimming in natural waters. Research cited by government and veterinary groups has found fipronil and imidacloprid in UK waters at levels that may harm aquatic invertebrates, while BVA, BSAVA, and BVZS have already backed more responsible, risk-based parasiticide use rather than blanket treatment. (gov.uk)

What to watch: Watch for the VMD’s response summary after the June 11, 2026 close, and for any later proposal to shift some flea and tick products from general retail access toward veterinary or pharmacy-only supply. (gov.uk)